Botanix Pharmaceuticals (Botanix Pharmaceuticals) Change In Receivables : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Botanix Pharmaceuticals Change In Receivables?

Botanix Pharmaceuticals's change in receivables for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Botanix Pharmaceuticals's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Botanix Pharmaceuticals's change in receivables for the fiscal year that ended in Jun. 2023 was $0.00 Mil. It means Botanix Pharmaceuticals's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

Botanix Pharmaceuticals's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.15 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Botanix Pharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2023 was 106.04.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Botanix Pharmaceuticals's liquidation value for the six months ended in Dec. 2023 was $11.88 Mil.

Botanix Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Botanix Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Change In Receivables Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

Get a 7-Day Free Trial

Botanix Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Botanix Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Botanix Pharmaceuticals (OTCPK:BXPHF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Botanix Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.147	/	0.253	*	91
=	106.04

2. In Ben Graham's calculation of liquidation value, Botanix Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Botanix Pharmaceuticals's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	12.258	-	1.533	+	0.75 * 0.147	+	0.5 * 2.096
=	11.88

Botanix Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (Botanix Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (OTCPK:BXPHF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BOT:Australia

Address

661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (Botanix Pharmaceuticals) Headlines

From GuruFocus

Botanix | World First Human Clinical Study Shows Synthetic CBD Formula Eradicates Staphylococcus Aureus

By Business Wire Business Wire • 02-03-2021